DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
rareLife solutions 606 Post Road East #397 Westport, CT 06880 |
||
You are receiving this because you have an account on www.oneAMYLOIDOSISvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: Community Center
Online support, community stories, financial assistance
Eric Polan’s Story
In November 2014, then 53-year-old Eric Polans was rushed to the emergency department of his local New Jersey hospital, with breathing problems. At the hospital, after five days of running tests, they believed he had two leaky heart valves. But there was a problem. The doctors felt his symptoms were not typical for leaky heart valves, so they were not sure what was causing his symptoms. Based on the hospital testing, Eric’s condition confounded his primary care doctor, who referred him to a cardiologist. But after four months, the cardiologist had yet to devise an effective treatment plan.
“The doctor was treating me for leaky heart valves and was considered having valve replacement surgery on me,” Eric recalls. “He decided to run one more test — an MRI of my heart. In that MRI they found the amyloid protein.”
Related Content
-
people & placesSally Arai, MDDr. Arai is an Associate Professor of Me...
-
people & placesAngela Dispenzieri, MDAngela Dispenzieri is a Chair of Hematol...
-
educationRecent Advances in Diagnosis and Treatment of Cardiac AmyloidosisCardiac amyloidosis (CA) has been believ...
-
news & meetingsFDA Approves Patisiran Infusion for Hereditary Transthyretin-Mediated AmyloidosisThe FDA announced that it has approved p...
-
people & placesRichard Lafayette, MDDr. Richard Lafayette is Professor of Me...
-
people & placesAmin Benyounes, MDDr. Amin Benyounes is a Thoracic Oncol...
-
videos & visualsStem Cell Transplant or Dara-CyBorD – ASG Webinar 12/13https://www.youtube.com/watch?v=4gUXPbOk...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.